Download PDF
Rofo 2016; 188(03): 259-267
DOI: 10.1055/s-0041-106899
Review
© Georg Thieme Verlag KG Stuttgart · New York

Interventional Ischemic Stroke Treatment – A (R)evolution

Die interventionelle Behandlung des ischämischen Schlaganfalls – eine (R)evolution
B. Friedrich
1   Department of Diagnostic and Interventional Radiology, University Hospital Leipzig, Germany
,
M. Gawlitza
2   Department of Neuroradiology, University Hospital Leipzig, Germany
,
J. Fahnert
1   Department of Diagnostic and Interventional Radiology, University Hospital Leipzig, Germany
,
U. Quäschling
2   Department of Neuroradiology, University Hospital Leipzig, Germany
,
T. Kahn
1   Department of Diagnostic and Interventional Radiology, University Hospital Leipzig, Germany
,
D. Lobsien
2   Department of Neuroradiology, University Hospital Leipzig, Germany
,
K.-T. Hoffmann
2   Department of Neuroradiology, University Hospital Leipzig, Germany
› Author Affiliations
Further Information

Publication History

10 July 2015

24 August 2015

Publication Date:
03 November 2015 (online)

Also available at
   Permissions and Reprints

Abstract

In recent years ischemic stroke caused by an intracranial vessel occlusion has become a treatable disease. Over decades intravenous thrombolysis by recombinant tissue plasminogen activator was the only accepted causal treatment of ischemic stroke supported by the results of randomized, controlled trials. However, there has been continuous development of endovascular treatment strategies over recent years. Today there are 5 prospective, randomized multicenter studies showing the highly significant superiority of endovascular, mechanical recanalization over intravenous thrombolysis in cases of acute occlusion of an intracranial vessel of the anterior circulation. In all those studies endovascular treatment resulted in a tremendous increase in functional independence together with a reduction of mortality without a significant increase in complications. This article reviews the developments resulting in the current data and gives an overview of the present studies focusing on endovascular stroke treatment.

Key Points:

• In the last 20 years ischemic stroke due to an main stem occlusion has become a potentially treatable disease.

• Several in 2015 published randomized Multicentener trials could prove the superiority of endovascular, mechanical recanalization over i.v. thrombolysis alone.

•  Acute ischemic stroke due to a main stem occlusion should be treated with swift endovascular stent-retriever based recanalization in specialized neurovascular centers.

Citation Format:

• Friedrich B, Gawlitza M, Fahnert J et al. Interventional Ischemic Stroke Treatment – A (R)evolution. Fortschr Röntgenstr 2016; 188: 1 – 9

Zusammenfassung

Der durch den Verschluss eines intrakraniellen Hauptstammes versursachte ischämische Schlaganfall hat sich in den letzten Jahren zu einer kausal behandelbaren Erkrankung entwickelt. Über Jahrzehnte war die intravenöse Lysetherapie mittels rekombinantem Tissue-Plasminogenaktivator einzige akzeptierte und durch die Ergebnisse randomisierter, kontrollierter Studien unterlegte ursächliche Behandlungsform des ischämischen Schlaganfalles. Jedoch hat in den letzten Jahren eine kontinuierliche Entwicklung endovaskulärer Behandlungskonzepte stattgefunden. Aktuell liegen 5 prospektive, randomisierte multizentrische Studien vor, die die hochsignifikante Überlegenheit der endovaskulären, mechanischen Rekanalisation gegenüber der intravenösen Lysetherapie bei akuten Verschlüssen der vorderen Zirkulation nachweisen. In all diesen Studien führte die endovaskuläre Behandlung zu einem deutlichen Anstieg des funktionell unabhängigen Lebens bei gleichzeitiger Reduktion der Mortalität ohne signifikanten Anstieg der Komplikationsraten. Dieser Artikel fasst die Entwicklungen, die zu diesen Ergebnissen geführt haben, zusammen und gibt eine Übersicht der aktuellen Studienlage zur Akuttherapie des ischämischen Schlaganfalls mit einem Fokus auf endovaskuläre Therapien.

Key words

brain - angiography - ischemia/infarction

Deutscher Artikel/German Article

 

  • References

  • 1 Adams HP, Bendixen BH, Kappelle LJ et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24: 35-41
    CrossrefPubMedGoogle Scholar
  • 2 Jansen O, von Kummer R, Forsting M et al. Thrombolytic therapy in acute occlusion of the intracranial internal carotid artery bifurcation. American Journal of Neuroradiology 1995; 16: 1977-1986
    PubMedGoogle Scholar
  • 3 Brandt T, von Kummer R, Müller-Küppers M et al. Thrombolytic therapy of acute basilar artery occlusion. Variables affecting recanalization and outcome. Stroke 1996; 27: 875-881
    CrossrefPubMedGoogle Scholar
  • 4 Hacke W, Schwab S, Horn M et al. “Malignant” middle cerebral artery territory infarction: clinical course and prognostic signs. Arch Neurol 1996; 53: 309-315
    CrossrefPubMedGoogle Scholar
  • 5 Meretoja A, Keshtkaran M, Saver JL et al. Stroke thrombolysis: save a minute, save a day. Stroke 2014; 45: 1053-1058
    CrossrefPubMedGoogle Scholar
  • 6 Tatlisumak T. Implication of the Recent Positive Endovascular Intervention Trials for Organizing Acute Stroke Care: European Perspective. Stroke 2015; 46: 1468-1473
    CrossrefPubMedGoogle Scholar
  • 7 Gustavsson A, Svensson M, Jacobi F et al. Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 2011; 21: 718-779
    Google Scholar
  • 8 The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581-1587
    CrossrefPubMedGoogle Scholar
  • 9 Hacke W, Kaste M, Fieschi C et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). Jama 1995; 274: 1017-1025
    CrossrefPubMedGoogle Scholar
  • 10 Moradiya Y, Crystal H, Valsamis H et al. Thrombolytic utilization for ischemic stroke in US hospitals with neurology residency program. Neurology 2013; 81: 1986-1995
    CrossrefPubMedGoogle Scholar
  • 11 Kleindorfer D, de los Rios La Rosa F, Khatri P et al. Temporal trends in acute stroke management. Stroke 2013; 44: S129-S131
    CrossrefPubMedGoogle Scholar
  • 12 Nasr DM, Brinjikji W, Cloft HJ et al. Utilization of intravenous thrombolysis is increasing in the United States. Int J Stroke 2013; 8: 681-688
    CrossrefPubMedGoogle Scholar
  • 13 Hacke W, Donnan G, Fieschi C et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004; 363: 768-774
    CrossrefPubMedGoogle Scholar
  • 14 Hacke W, Kaste M, Bluhmki E et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008; 359: 1317-1329
    CrossrefPubMedGoogle Scholar
  • 15 Wahlgren N, Ahmed N, Dávalos A et al. Thrombolysis with alteplase 3–4.5h after acute ischaemic stroke (SITS-ISTR): an observational study. Lancet 2008; 372: 1303-1309
    CrossrefPubMedGoogle Scholar
  • 16 Alexandrov AV, Molina CA, Grotta JC et al. Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med 2004; 351: 2170-2178
    CrossrefPubMedGoogle Scholar
  • 17 Ding D. Intravenous versus intra-arterial thrombolysis for anterior circulation stroke secondary to large vessel occlusion. J Stroke Cerebrovasc Dis 2015; 24: 718-719
    CrossrefPubMedGoogle Scholar
  • 18 Zeumer H, Hacke W, Kolmann HL et al. Local fibrinolysis in basilar artery thrombosis. Dtsch Med Wochenschr 1982; 107: 728-731
    Article in Thieme ConnectPubMedGoogle Scholar
  • 19 Furlan A, Higashida R, Wechsler L et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. Jama 1999; 282: 2003-2011
    CrossrefPubMedGoogle Scholar
  • 20 Gobin YP, Starkman S, Duckwiler GR et al. MERCI 1: a phase 1 study of Mechanical Embolus Removal in Cerebral Ischemia. Stroke 2004; 35: 2848-2854
    CrossrefPubMedGoogle Scholar
  • 21 Smith WS, Sung G, Starkman S et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005; 36: 1432-1438
    CrossrefPubMedGoogle Scholar
  • 22 Smith WS, Sung G, Saver J et al. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke 2008; 39: 1205-1212
    CrossrefPubMedGoogle Scholar
  • 23 Brekenfeld C, Schroth G, El-Koussy M et al. Mechanical thromboembolectomy for acute ischemic stroke: comparison of the catch thrombectomy device and the Merci Retriever in vivo. Stroke 2008; 39: 1213-1219
    CrossrefPubMedGoogle Scholar
  • 24 Bose A, Henkes H, Alfke K et al. The Penumbra System: a mechanical device for the treatment of acute stroke due to thromboembolism. Am J Neuroradiol 2008; 29: 1409-1413
    CrossrefPubMedGoogle Scholar
  • 25 Penumbra Pivotal Stroke Trial Investigators. The penumbra pivotal stroke trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke 2009; 40: 2761-2768
    CrossrefPubMedGoogle Scholar
  • 26 Pérez MA, Miloslavski E, Fischer S et al. Intracranial thrombectomy using the Solitaire stent: a historical vignette. J Neurointerv Surg 2012; 4: e32-e32
    CrossrefPubMedGoogle Scholar
  • 27 Saver JL, Jahan R, Levy EI et al. Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet 2012; 380: 1241-1249
    CrossrefPubMedGoogle Scholar
  • 28 Dorn F, Stehle S, Lockau H et al. Endovascular treatment of acute intracerebral artery occlusions with the solitaire stent: single-centre experience with 108 recanalization procedures. Cerebrovasc Dis 2012; 34: 70-77
    CrossrefPubMedGoogle Scholar
  • 29 Cohen JE, Gomori JM, Leker RR et al. Preliminary experience with the use of self-expanding stent as a thrombectomy device in ischemic stroke. Neurol Res 2011; 33: 214-219
    CrossrefPubMedGoogle Scholar
  • 30 Broderick JP, Palesch YY, Demchuk AM et al. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med 2013; 368: 893-903
    CrossrefPubMedGoogle Scholar
  • 31 Kidwell CS, Jahan R, Gornbein J et al. A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med 2013; 368: 914-923
    CrossrefPubMedGoogle Scholar
  • 32 Ciccone A, Valvassori L, Nichelatti M et al. Endovascular treatment for acute ischemic stroke. N Engl J Med 2013; 368: 904-913
    CrossrefPubMedGoogle Scholar
  • 33 von Kummer R, Gerber J. IMS-3, synthesis, and MR Rescue: no disaster, but down to earth. Clin Neuroradiol 2013; 23: 1-3
    PubMedGoogle Scholar
  • 34 Berkhemer OA, Fransen PSS, Beumer D et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 2015; 372: 11-20
    CrossrefPubMedGoogle Scholar
  • 35 Goyal M, Demchuk AM, Menon BK et al. Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke. N Engl J Med 2015; 150211090353006
    PubMedGoogle Scholar
  • 36 Campbell BCV, Mitchell PJ, Kleinig TJ et al. Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging Selection. N Engl J Med 2015; 150211090353006
    PubMedGoogle Scholar
  • 37 Saver JL, Goyal M, Bonafe A et al. Stent-Retriever Thrombectomy after Intravenous t-PA vs. t-PA Alone in Stroke. N Engl J Med 2015; 150417023017004
    PubMedGoogle Scholar
  • 38 Jovin TG, Chamorro A, Cobo E et al. Thrombectomy within 8 Hours after Symptom Onset in Ischemic Stroke. N Engl J Med 2015; 150417035025009
    PubMedGoogle Scholar
  • 39 Sardar P, Chatterjee S, Giri J et al. Endovascular therapy for acute ischaemic stroke: a systematic review and meta-analysis of randomized trials. Eur Heart J 2015; 36: 2373-2380
    CrossrefPubMedGoogle Scholar
  • 40 Consensus statement on mechanical thrombectomy in acute ischemic stroke – ESO-Karolinska Stroke Update 2014 in collaboration with ESMINT and ESNR. http://www.Strokeupdate.org/consensus-Statement-Mechanical-Thrombectomy-Acute-Ischemic-Stroke
    PubMedGoogle Scholar
  • 41 Powers WJ, Derdeyn CP, Biller J et al. 2015 AHA/ASA Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke 2015; 46: 3020-3035
    CrossrefPubMedGoogle Scholar
  • 42 Navia P, Larrea JA, Pardo E et al. Initial experience using the 3MAX cerebral reperfusion catheter in the endovascular treatment of acute ischemic stroke of distal arteries. J Neurointerv Surg 2015; neurintsurg–2015–011798
    PubMedGoogle Scholar
  • 43 Dorn F, Lockau H, Stetefeld H et al. Mechanical Thrombectomy of M2-Occlusion. J Stroke Cerebrovasc Dis 2015; 24: 1465-1470
    CrossrefPubMedGoogle Scholar
  • 44 Porelli S, Leonardi M, Stafa A et al. CT angiography in an acute stroke protocol: correlation between occlusion site and outcome of intravenous thrombolysis. Interv Neuroradiol 2013; 19: 87-96
    PubMedGoogle Scholar
  • 45 Friedrich B, Gawlitza M, Schob S et al. Distance to thrombus in acute middle cerebral artery occlusion: a predictor of outcome after intravenous thrombolysis for acute ischemic stroke. Stroke 2015; 46: 692-696
    CrossrefPubMedGoogle Scholar
  • 46 van der Hoeven EJRJ, Schonewille WJ, Vos JA et al. The Basilar Artery International Cooperation Study (BASICS): study protocol for a randomised controlled trial. Trials 2013; 14: 200
    CrossrefPubMedGoogle Scholar
  • 47 Schönenberger S, Möhlenbruch M, Pfaff J et al. Sedation vs. Intubation for Endovascular Stroke TreAtment (SIESTA) – a randomized monocentric trial. Int J Stroke 2015; 10: 969-978
    CrossrefPubMedGoogle Scholar